BIOPHARMIA AS

0495 OSLO

Finances

Share Ownership

Return on Equity

−1,2 %

Current Ratio

0,37

Debt-to-Equity Ratio

0,26

Key figures (NOK)	2022	2021	2020	2019
Revenue	0	0	11 000	53 000
Net Income	−100 000	−133 000	−22 000	286 000
Total Assets	10 568 000	10 557 000	10 567 000	10 651 000
Total Equity	8 341 000	8 442 000	8 575 000	8 597 000

Income (NOK)	2022	2021	2020	2019
Revenue	0	0	11 000	53 000
Expenditure	100 000	133 000	33 000	−234 000
Operating Profit	−100 000	−133 000	−22 000	286 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Earnings Before Tax	−100 000	−133 000	−22 000	286 000
Tax	0	0	0	0
Net Income	−100 000	−133 000	−22 000	286 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	10 551 000	10 551 000	10 551 000	10 551 000
Total Current Assets	17 000	6 000	16 000	100 000
Total Assets	10 568 000	10 557 000	10 567 000	10 651 000
Total Retained Equity	−1 942 000	−1 842 000	−1 709 000	−1 686 000
Total Equity	8 341 000	8 442 000	8 575 000	8 597 000
Total Long-Term Debt	2 181 000	2 073 000	1 955 000	1 912 000
Total Current Debt	46 000	42 000	37 000	142 000
Total Equity and Debt	10 568 000	10 557 000	10 567 000	10 651 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	0	0	11 000	53 000
Revenue	0	0	11 000	53 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	100 000	133 000	33 000	−234 000
Operating Profit	−100 000	−133 000	−22 000	286 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Dividends	0	0	0	0
Net Income	−100 000	−133 000	−22 000	286 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	10 551 000	10 551 000	10 551 000	10 551 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	10 551 000	10 551 000	10 551 000	10 551 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	0	6 000	1 000	1 000
Total Current Assets	17 000	6 000	16 000	100 000
Total Assets	10 568 000	10 557 000	10 567 000	10 651 000
Total Equity	8 341 000	8 442 000	8 575 000	8 597 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 181 000	2 073 000	1 955 000	1 912 000
Creditors	30 000	25 000	13 000	126 000
Unpaid Taxes	0	1 000	9 000	0
Dividends	0	0	0	0
Other Current Debt	16 000	16 000	16 000	16 000
Total Current Debt	46 000	42 000	37 000	142 000
Total Equity and Debt	10 568 000	10 557 000	10 567 000	10 651 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−1,2 %	−1,58 %	−0,26 %	3,33 %
Debt-to-Equity Ratio	0,26	0,25	0,23	0,22
Operating Profit Margin	-	-	−200 %	539,62 %
Current Ratio	0,37	0,14	0,43	0,7
Quick Ratio	0,37	0,14	0,43	0,7
Equity Ratio	0,79	0,8	0,81	0,81
Gross Profit Margin	-	-	100 %	100 %